648 — SoftMedx Healthcare Income Statement
0.000.00%
Last trade - 00:00- HK$531.51m
- HK$532.13m
- HK$68.24m
Annual income statement for SoftMedx Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.7 | 33.8 | 51.3 | 54.6 | 68.2 |
| Cost of Revenue | |||||
| Gross Profit | 0.79 | 13.7 | 21.1 | 18.4 | 22.6 |
| Selling / General / Administrative Expenses | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.1 | 34.8 | 24 | -275 | 57.4 |
| Operating Profit | -8.45 | -1.08 | 27.3 | 329 | 10.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -24.7 | -16.6 | 14.4 | 328 | 9.45 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -24.7 | -19.2 | 12.5 | 326 | 6.95 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -26.3 | -19.2 | 12.5 | 326 | 6.95 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -26.3 | -19.2 | 12.5 | 326 | 6.95 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.105 | -0.059 | 0.051 | 0.347 | 0.012 |